image
Evoke Pharma, Inc. EVOK
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 4.58
4.33 %
$ 6.81 M
Market Cap
-0.45
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 106.51% 4.53% 4.56%
Annual Report FY 10-K 2022-12-31 55.04% 9.60% 4.48%
Annual Report FY 10-K 2021-12-31 6929.00% 31.92% 37.52%
Annual Report FY 10-K 2020-12-31 0.00% -86.87% -82.37%
Annual Report FY 10-K 2019-12-31 0.00% 6.20% 10.73%
Annual Report FY 10-K 2018-12-31 0.00% 38.13% 28.64%
Annual Report FY 10-K 2017-12-31 0.00% -13.78% -6.51%
Annual Report FY 10-K 2016-12-31 0.00% 11.33% 10.78%
Annual Report FY 10-K 2015-12-31 0.00% 8.50% 10.13%
Annual Report FY 10-K 2014-12-31 0.00% -367.05% -405.42%
Annual Report FY 10-K 2013-12-31 0.00% -40.59% -29.93%
Annual Report FY 10-K 2012-12-31 0.00% 15.98% 17.07%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 69.83% 22.52% 19.82%
Quarterly Report Q2 8-K 2024-06-30 125.51% 32.16% 31.43%
Quarterly Report Q1 8-K 2024-03-31 114.15% 35.63% 30.34%
Quarterly Report Q4 8-K 2023-12-31 110.45% -12.24% -10.42%
Quarterly Report Q3 8-K 2023-09-30 87.82% 15.89% 16.16%
Quarterly Report Q2 8-K 2023-06-30 144.99% 16.22% 15.54%
Quarterly Report Q1 8-K 2023-03-31 93.70% -12.95% -5.07%
Quarterly Report Q4 8-K 2022-12-31 120.86% -5.88% -10.50%
Quarterly Report Q3 8-K 2022-09-30 -10.57% -2.26% -3.67%
Quarterly Report Q2 8-K 2022-06-30 95.15% 2.67% 2.60%
Quarterly Report Q1 8-K 2022-03-31 362.70% 16.60% 20.82%
Quarterly Report Q4 8-K 2021-12-31 1466.34% 26.26% 29.95%
Quarterly Report Q3 8-K 2021-09-30 0.00% 7.50% 11.29%
Quarterly Report Q2 8-K 2021-06-30 0.00% 67.12% 68.86%
Quarterly Report Q1 8-K 2021-03-31 0.00% -45.53% -44.42%
Quarterly Report Q4 8-K 2020-12-31 0.00% -59.91% -55.12%
Quarterly Report Q3 8-K 2020-09-30 0.00% -30.78% -27.06%
Quarterly Report Q2 8-K 2020-06-30 0.00% -229.57% -227.96%
Quarterly Report Q1 8-K 2020-03-31 0.00% 8.90% 8.95%
Quarterly Report Q4 8-K 2019-12-31 0.00% 19.45% 19.47%
Quarterly Report Q3 8-K 2019-09-30 0.00% -7.15% -7.49%
Quarterly Report Q2 8-K 2019-06-30 0.00% 8.21% 7.91%
Quarterly Report Q1 8-K 2019-03-31 0.00% 0.88% 18.52%
Quarterly Report Q4 8-K 2018-12-31 0.00% -470.81% 33.50%
Quarterly Report Q3 8-K 2018-09-30 0.00% 71.02% 58.87%
Quarterly Report Q2 8-K 2018-06-30 0.00% -41.65% 20.19%
Quarterly Report Q1 8-K 2018-03-31 0.00% 60.75% -22.09%
Quarterly Report Q4 8-K 2017-12-31 0.00% 79.81% -14.40%
Quarterly Report Q3 8-K 2017-09-30 0.00% -73.31% -70.63%
Quarterly Report Q2 8-K 2017-06-30 0.00% 45.26% 0.28%
Quarterly Report Q1 8-K 2017-03-31 0.00% -56.63% 37.19%
Quarterly Report Q4 8-K 2016-12-31 0.00% 41.80% 8.89%
Quarterly Report Q3 8-K 2016-09-30 0.00% -10.60% 18.36%
Quarterly Report Q2 8-K 2016-06-30 0.00% 8.35% 8.43%
Quarterly Report Q1 8-K 2016-03-31 0.00% 8.39% 8.49%
Quarterly Report Q4 8-K 2015-12-31 0.00% 10.13% 12.47%
Quarterly Report Q3 8-K 2015-09-30 0.00% 28.49% 30.45%
Quarterly Report Q2 8-K 2015-06-30 0.00% 8.62% 9.37%
Quarterly Report Q1 8-K 2015-03-31 0.00% -19.13% -17.88%
Quarterly Report Q4 8-K 2014-12-31 0.00% -80.60% -84.36%
Quarterly Report Q3 8-K 2014-09-30 0.00% -687.27% -686.91%
Quarterly Report Q2 8-K 2014-06-30 0.00% -1378.73% -1616.55%
Quarterly Report Q1 8-K 2014-03-31 0.00% -498.29% -780.22%
Quarterly Report Q4 8-K 2013-12-31 0.00% -140.42% -138.82%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.07% -1.64%
Quarterly Report Q2 8-K 2013-06-30 0.00% 33.12% 43.55%
Quarterly Report Q1 8-K 2013-03-31 0.00% 1.23% 33.91%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2012-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2012-03-31 0.00% 0.00% 0.00%